Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Henderson, WA
Angus J. Henderson, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20100085632 | METHOD AND APPARATUS FOR PUMPING AND OPERATING OPTICAL PARAMETRIC OSCILLATORS USING DFB FIBER LASERS - An optical parametric oscillator (OPO) is described that efficiently converts a near-infrared laser beam to tunable mid-infrared wavelength output. In some embodiments, the OPO includes an optical resonator containing a nonlinear crystal, such as periodically-poled lithium niobate. The OPO is pumped by a continuous-wave fiber-laser source having a low-power oscillator and a high-power amplifier, or using just a power oscillator. The fiber oscillator produces a single-frequency output defined by a distributed-feedback (DFB) structure of the fiber. The DFB-fiber-laser output is amplified to a pump level consistent with exceeding an oscillation threshold in the OPO in which only one of two generated waves (“signal” and “idler”) is resonant within the optical cavity. This pump source provides the capability to tune the DFB fiber laser by straining the fiber (using an attached piezoelectric element or by other means) that allows the OPO to be continuously tuned over substantial ranges, enabling rapid, wide continuous tuning of the OPO output frequency or frequencies. | 04-08-2010 |
Gary Henderson, Redmond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110099537 | EVENT HANDLING FOR UNMANAGED CODE - Many computer applications involve event driven programming. Unfortunately, it may be burdensome on application developers to develop event handlers in unmanaged code for all relevant events within their computer application. For example, when using COM objects in connection with event handling, the burden of lifetime management may be placed on the application developer. Accordingly, one or more systems and/or techniques for event handling in unmanaged code are disclosed herein. A delegate comprising a first interface and a second interface is provided. The delegate may receive event data from a software platform connected to the first interface and may notify a function of a process connected to the second interface. The delegate self destructs when both the computing platform and the process have released their connections to the respective interfaces, thus mitigating manual coding of lifetime management functionality within the process. | 04-28-2011 |
Gary S. Henderson, Redmond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110043535 | COLORIZATION OF BITMAPS - A bitmap may be transformed from one color scheme to another. In one example, the bitmap is used as part of a user interface (UI), and the colorization is performed to reflect a user's (or some other entity's) choice of color scheme. To perform the colorization, a bitmap may be converted from the red-green-blue (RGB) color space to the hue-saturation-lightness (HSL) color space. The hue may then be rotated toward the selected color scheme. Lightness and alpha (opacity) may be gamma-adjusted toward the selected color scheme. Saturation may be linearly adjusted upward or downward in the direction of the selected color scheme. The transformed HSL representation of the image may then be converted from the HSL space back to the RGB space. The new RGB bitmap may then be used to render one or more UI elements. | 02-24-2011 |
Heather Henderson, Vancouver, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110248533 | EXTENDABLE STROLLER SHADE - A stroller or carseat shade is formed from a fabric having a middle section tapered on two sides. Rod tunnels run from a first taper across the middle section to a second taper. An elastic section is formed to wrap around and cling to an existing canopy on a stroller or car seat. The shade is symmetrical relative to a front to back axis. Fasteners are positioned at a series of overlapping stop positions parallel to the front to back axis. | 10-13-2011 |
Jenifer Lee Henderson, Bainbridge Island, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20120046759 | TEMPORAL BROW LIFTING AND FIXATION DEVICE - The present invention describes an implantable tissue lifting and fixation device. More particularly, the present invention describes a temporal brow lifting device comprised of a bio-absorbable supportive backing. The device has a shape of a curvilinear end and a tail end region. The curvilinear end region comprises a plurality of attachment points protruding from the supportive backing, and the tail region comprises of a plurality of cavities in order to secure the device at the desired elevated position in the deep temporal fascia. The plurality of attachment points distributes tension in a multi-vector direction over the contact area between the device and the tissue. The attachment points can be manufactured separately and attached, however, preferably, the attachment points are made integral with the temporal brow lifting device. | 02-23-2012 |
Jenifer Lee Henderson, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080200993 | Temporal Brow Lifting and Fixation Device - The present invention describes an implantable tissue lifting and fixation device. More particularly, the present invention describes a temporal brow lifting device comprises of a bio-absorbable supportive backing. The device has a shape of a curvilinear end and a tail end region. The curvilinear end region comprises a plurality of attachment points protruding from the supportive backing, and the tail region comprises of a plurality of cavities in order to secure the device at the desired elevated position in the deep temporal fascia. The plurality of attachment points distributes tension in a multi-vector direction over the contact area between the device and the tissue. The attachment points can be manufactured separately and attached, however, preferably, the attachment points are made integral with the temporal brow lifting device. | 08-21-2008 |
Katherine E. Henderson, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090018080 | METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS - IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on viruses that infect liver, such as hepatitis B virus and hepatitis C virus. In addition, IL-28A, IL-28B, IL-29, and mutants thereof do not exhibit some of the antiproliferative activity on hematopoietic cells that is observed with interferon treatment. Without the immunosuppressive effects accompanying interferon treatment, IL-28A, IL-28B, and IL-29 will be useful in treating immunocompromised patients for viral infections. | 01-15-2009 |
| 20090263352 | METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS - IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on viruses that infect liver, such as hepatitis B virus and hepatitis C virus. In addition, IL-28A, IL-28B, IL-29, and mutants thereof do not exhibit some of the antiproliferative activity on hematopoietic cells that is observed with interferon treatment. Without the immunosuppressive effects accompanying interferon treatment, IL-28A, IL-28B, and IL-29 will be useful in treating immunocompromised patients for viral infections. | 10-22-2009 |
| 20100297068 | METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 - IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on viruses that infect liver, such as hepatitis B virus and hepatitis C virus. In addition, IL-28A, IL-28B, IL-29, and mutants thereof do not exhibit some of the antiproliferative activity on hematopoietic cells that is observed with interferon treatment. Without the immunosuppressive effects accompanying interferon treatment, IL-28A, IL-28B, and IL-29 will be useful in treating immunocompromised patients for viral infections. | 11-25-2010 |
| 20110008280 | METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS - IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on viruses that infect liver, such as hepatitis B virus and hepatitis C virus. In addition, IL-28A, IL-28B, IL-29, and mutants thereof do not exhibit some of the antiproliferative activity on hematopoietic cells that is observed with interferon treatment. Without the immunosuppressive effects accompanying interferon treatment, IL-28A, IL-28B, and IL-29 will be useful in treating immunocompromised patients for viral infections. | 01-13-2011 |
| 20110171627 | ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS - Novel methods are disclosed for forming a heterodimeric receptor complex with IL-28R and CRF2-4. The methods may be used for detecting and treating viral infections in in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto. | 07-14-2011 |
| 20110300101 | Methods for treating viral infection using IL-28 and IL-29 Cysteine mutants - IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on viruses that infect liver, such as hepatitis B virus and hepatitis C virus. In addition, IL-28A, IL-28B, IL-29, and mutants thereof do not exhibit some of the antiproliferative activity on hematopoietic cells that is observed with interferon treatment. Without the immunosuppressive effects accompanying interferon treatment, IL-28A, IL-28B, and IL-29 will be useful in treating immunocompromised patients for viral infections. | 12-08-2011 |
| 20120020919 | METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 - IL-28A, IL-28B, IL-29, and certain mutants thereof have been shown to have antiviral activity on a spectrum of viral species. Of particular interest is the antiviral activity demonstrated on viruses that infect liver, such as hepatitis B virus and hepatitis C virus. In addition, IL-28A, IL-28B, IL-29, and mutants thereof do not exhibit some of the antiproliferative activity on hematopoietic cells that is observed with interferon treatment. Without the immunosuppressive effects accompanying interferon treatment, IL-28A, IL-28B, and IL-29 will be useful in treating immunocompromised patients for viral infections. | 01-26-2012 |
Mark Henderson, Pasco, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090099004 | CONTINUOUS PRODUCTION OF CARBON NANOMATERIALS USING A HIGH TEMPERATURE INDUCTIVELY COUPLED PLASMA - High-power inductively coupled plasma technology is used for thermal cracking and vaporization of continuously fed carbonaceous materials into elemental carbon, for reaction with separate and continuously fed metal catalysts inside a gas-phase high-temperature reactor system operating at or slightly below atmospheric pressures. In one particularly preferred embodiment, in-flight growth of carbon nanomaterials is initiated, continued, and controlled at high flow rates, enabling continuous collection and product removal via gas/solid filtration and separation methods, and/or liquid spray filtration and solid collection methods suitable for producing industrial-scale production quantities. In another embodiment, the reaction chamber and/or filtration/separation media include non-catalytic or catalytic metals to simultaneously or separately induce on-substrate synthesis and growth of carbon nanomaterials. The on-substrate grown carbon nanomaterials are produced in secondary chambers that are selectively isolated for periodic removal of the product. | 04-16-2009 |
| 20100025225 | CONTINUOUS PRODUCTION OF CARBON NANOMATERIALS USING A HIGH TEMPERATURE INDUCTIVELY COUPLED PLASMA - High-power inductively coupled plasma technology is used for thermal cracking and vaporization of continuously fed carbonaceous materials into elemental carbon, for reaction with separate and continuously fed metal catalysts inside a gas-phase high-temperature reactor system operating at or slightly below atmospheric pressures. In one particularly preferred embodiment, in-flight growth of carbon nanomaterials is initiated, continued, and controlled at high flow rates, enabling continuous collection and product removal via gas/solid filtration and separation methods, and/or liquid spray filtration and solid collection methods suitable for producing industrial-scale production quantities. In another embodiment, the reaction chamber and/or filtration/separation media include non-catalytic or catalytic metals to simultaneously or separately induce on-substrate synthesis and growth of carbon nanomaterials. The on-substrate grown carbon nanomaterials are produced in secondary chambers that are selectively isolated for periodic removal of the product. | 02-04-2010 |
Paul E. Henderson, Redmond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20120072446 | TECHNIQUES USING CAPTURED INFORMATION - Techniques are provided utilizing captured information. The captured information includes at least one of audio and image information. In response to connecting a capture device including the captured information to another device, the captured information is downloaded to the other device, a text portion is formed corresponding to the captured information, and at least a portion of the captured information and text portion is stored. A selected action is automatically performed using at least one of the text portion and the captured information. | 03-22-2012 |
Raymond N. Henderson, Renton, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080264357 | CONTROL OF DETONATIVE CLEANING APPARATUS - An apparatus is provided for cleaning one or more surfaces within a vessel having a vessel wall separating a vessel exterior from a vessel interior and having a wall aperture. The apparatus has at least one elongate conduit having an upstream first end and a downstream second end and positioned to direct a shockwave from the second end into the vessel interior. A source of fuel and oxidizer is coupled to the conduit to deliver the fuel and oxidizer to the conduit An initiator is positioned to initiate a reaction of the fuel and oxidizer to produce the shockwave. At least one sensor coupled to the conduit to detect motion indicative of a detonation. A control system coupled to the initiator, the source, and the sensor for receiving input from the sensor and controlling operation of the initiator and source responsive to said input. | 10-30-2008 |
Raymond N. Henderson, Federal Way, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20100043941 | Composite Spar Drape Forming Machine - A machine and a method for forming composite materials are provided. The machine includes a frame and at least one forming beam attached to the frame, the at least one beam being arranged to align with a mandrel. The forming beam is pivotally segmented into at least two segments to conform to the shape of the mandrel, or alternately is bendable to conform to the shape of the mandrel. The mandrel is receivable within the frame in alignment with the forming beam. An apparatus is also provided to position a composite charge over the mandrel, and to position the mandrel within the frame. A further apparatus is provided to transport the mandrel, and to urge the mandrel toward the forming beam, forming a composite charge. | 02-25-2010 |
Robert A. Henderson, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080293103 | STRESS PROTEIN COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CANCER AND INFECTIOUS DISEASE - Pharmaceutical compositions comprising a stress protein complex and related molecules encoding or cells presenting such a complex are provided. The stress protein complex comprises an hsp110 or grp170 polypeptide complexed with an immunogenic polypeptide. The immunogenic polypeptide of the stress protein complex can be associated with a cancer or an infectious disease. Preferred immunogenic polypeptides include gp100, her2/neu ECD-PD, ICD and | 11-27-2008 |
Vincent Henderson, Snohomish, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080320460 | Fulfillment of requirement for versioned resource - A requirement for a versioned resource is fulfilled, particularly in light of compatibility constraints of the requirement. Versions of the versioned resource are associated with compatibility information, such as a feature version and a service version, for example. In fulfilling the requirement, compatibility logic may be applied to identify versions that are compatible with the requirement, and selection logic may be applied to select a preferred version from the compatible versions. | 12-25-2008 |
William R. Henderson, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080242669 | METHODS RELATING TO THE TREATMENT OF FIBROTIC DISORDERS - The invention provides α-mimetic structure of formula (I), wherein A is —(C═O)—(CHR | 10-02-2008 |
| 20090176742 | METHODS RELATING TO THE TREATMENT OF FIBROTIC DISORDERS - The invention provides α-mimetic structure of formula (I), wherein A is —(C═O)—(CHR | 07-09-2009 |